Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tissue explants as tools for studying the epigenetic modulation of the GH-IGF-I axis in farmed fish

  • Perera, Erick
  • Román-Padilla, Javier
  • Hidalgo-Pérez, Juan Antonio
  • Huesa-Cerdán, Rubén
  • Yúfera, Manuel
  • Mancera, Juan Miguel
  • Martos-Sitcha, Juan Antonio
  • Martínez-Rodríguez, Gonzalo
  • Ortiz-Delgado, Juan B.
  • Navarro-Guillén, Carmen
  • Rodríguez-Casariego, Javier
Somatic growth in vertebrates is mainly controlled by the growth hormone (GH)/insulin-like growth factor I (IGF-I) axis. The role of epigenetic mechanisms in regulating this axis in fish is far from being understood. This work aimed to optimize and evaluate the use of short-term culture of pituitary and liver explants from a farmed fish, the gilthead seabream Sparus aurata, for studying epigenetic mechanisms involved in GH/IGF-I axis regulation. Our results on viability, structure, proliferation, and functionality of explants support their use in short-term assays. Pituitary explants showed no variation in gh expression after exposure to the DNA methylation inhibitor decitabine (5-Aza-2'-deoxycytidine; DAC), despite responding to DAC by changing dnmt3bb and tet1 expression, and TET activity, producing an increase in overall DNA hydroxymethylation. Conversely, in liver explants, DAC had no effects on dnmt s and tet s expression or activity, but modified the expression of genes from the GH-IGF-I axis. In particular, the expression of igfbp2a was increased and that of igfbp4, ghri and ghrii was decreased by DAC as well as by genistein, which is suggestive of impaired growth. While incubation of liver explants with S-adenosylmethionine (SAM) produced no clear effects, it is proposed that nutrients must ensure the methylation milieu within the liver in the fish to sustain proper growth, which need further in vivo verification. Pituitary and liver explants from S. aurata can be further used as described herein for the screening of inhibitors or activators of epigenetic regulators, as well as for assessing epigenetic mechanisms behind GH-IGF-I variation in farmed fish., This research was funded by the project BreamEpiMap (Grant: PID 2021-128540OA-I00) funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, and by project epiMODEL2 (ref 202240I011, CSIC), both granted to EP. CN-G was supported by the researcher contract DOC_01203 funded by the Andalusian Plan for Research Development and Innovation (PAIDI 2020). JR-P was supported by ALEHOOP Project N° 887259 H2020-BBI-JTI-2019. JH-P was supported by program Garantía Juvenil from European Union through Junta de Andalucía, Spain, and RH-C by program Investigo financed by the European Union, NextGenerationEU through the Spanish Recovery, Transformation and Resilience Plan (RRTP)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effect of algal extracts on the metabolism, intestinal functionality and oxidative status of gilthead seabream (Sparus aurata)

  • Martínez-Antequera, F. P.
  • Simó-Mirabet, Paula
  • Román, M.
  • Álvaro-Fuentes, Jorge
  • Oliva, M.
  • Méndez-Paz, D.
  • Vázquez-Sobrado, R.
  • Martos-Sitcha, Juan Antonio
  • Moyano, F. J.
  • Mancera, J. M.
Intensive aquaculture systems are associated with decrease in water quality and increased environmental stress and disease prevalence. This promotes the exploration of bioactive compounds that can be included in aquafeeds to enhance fish resilience under such negative conditions. The present study investigated the effects of dietary supplementation with two different extracts obtained from the green seaweed Ulva spp. on the growth performance, intestinal functionality, metabolic profile and oxidative status of gilthead sea bream (Sparus aurata). These extracts, either characterized to be enriched in protein (P) or carbohydrate (F) fractions, were included at 12 % in respective diets. After a 42-day feeding trial, a 10-day starvation challenge was conducted as a putative proof-of-concept on the effects of bioactive compounds under food-deprivation. No significant differences in growth performance were observed between the experimental groups during the feeding period. However, after starvation challenge, fish fed the Ulva-based diets exhibited reduced weight loss (∼5 % lower than the control group), indicating enhanced physiological resilience. No significant effect of the inclusion of algal extracts was observed on intestinal morphology or functionality. Biochemical analyses revealed that plasma lactate levels were significantly lower (∼15 %) in the P group, while plasma protein concentrations were reduced (∼9 %) in the F group compared to the control. Hepatic glycogen depletion was more pronounced in fish fed both supplemented-experimental diets after the starving period. Conversely, oxidative stress markers indicated enhanced antioxidant capacity in both experimental groups. Superoxide dismutase (SOD) activity was significantly higher (∼13 %), while malondialdehyde (MDA) levels, a marker of lipid peroxidation, were ∼ 15 % lower in Ulva-fed fish compared to controls. These findings suggest that Ulva spp. extracts may confer metabolic and antioxidant benefits, particularly under starvation-induced stress, without compromising growth performance. Further research is warranted to optimize inclusion rates and elucidate their long-term impacts., This work has been financed by project ALEHOOP (Biorefineries for the valorization of macroalgal residual biomass and legume processing by-products to obtain new protein value-chains for high-value food and feed applications; H2020-BBI-JTI-2019, proposal n°: 887259, UE) funded by the European Union under the Horizon Europe Programme. P. Simó-Mirabet is supported by a Postdoctoral Research Fellowship (Juan de la Cierva-Formación, Reference FJCI-2021-047759-I) from Spanish Ministry of Science and Innovation)., Peer reviewed
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

  • Diz Chaves, Yolanda Maria
  • Maastor, Zainab
  • Spuch Calvar, Carlos
  • Lamas Castro, José Antonio
  • González Matías, Lucas Carmelo
  • Mallo Ferrer, Federico
The glucagon-like peptide 1 is a pleiotropic hormone that has potent insulinotropic effects and is key in treating metabolic diseases such as diabetes and obesity. Glucagon-like peptide 1 exerts its effects by activating a membrane receptor identified in many tissues, including different brain regions. Glucagon-like peptide 1 activates several signaling pathways related to neuroprotection, like the support of cell growth/survival, enhancement promotion of synapse formation, autophagy, and inhibition of the secretion of proinflammatory cytokines, microglial activation, and apoptosis during neural morphogenesis. The glial cells, including astrocytes and microglia, maintain metabolic homeostasis and defense against pathogens in the central nervous system. After brain insult, microglia are the first cells to respond, followed by reactive astrocytosis. These activated cells produce proinflammatory mediators like cytokines or chemokines to react to the insult. Furthermore, under these circumstances, microglia can become chronically inflammatory by losing their homeostatic molecular signature and, consequently, their functions during many diseases. Several processes promote the development of neurological disorders and influence their pathological evolution: like the formation of protein aggregates, the accumulation of abnormally modified cellular constituents, the formation and release by injured neurons or synapses of molecules that can dampen neural function, and, of critical importance, the dysregulation of inflammatory control mechanisms. The glucagon-like peptide 1 receptor agonist emerges as a critical tool in treating brain-related inflammatory pathologies, restoring brain cell homeostasis under inflammatory conditions, modulating microglia activity, and decreasing the inflammatory response. This review summarizes recent advances linked to the anti-inflammatory properties of glucagon-like peptide 1 receptor activation in the brain related to multiple sclerosis, Alzheimer's disease, Parkinson's disease, vascular dementia, or chronic migraine., Xunta de Galicia | Ref. ED431G/02
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Red seaweed proteins: Valuable marine-origin compounds with encouraging applications

  • Jimenez Gonzalez, Camila
  • Torrado Agrasar, Ana María
  • Mallo Ferrer, Federico
  • Rua Rodriguez, María Luisa
  • Fuciños González, Clara
Increased incomes, urbanization, and an aging population, are leading to changes in consumption patterns, resulting in a growing demand for proteins. From a sustainability perspective, there is a consensus that animal protein production has a disproportionately impact on the environment, particularly in intensive systems that require significant amounts of feed crops. Macroalgae have emerged as a promising feedstock for transitioning towards a blue bioeconomy. Red seaweed stands out as a particularly attractive action, as it can contain protein concentrations of up to 47 %, the highest among terrestrial plants and other algae divisions. These proteins offer a rich source of essential amino acids, making them excellent candidates for human food formulation. Nevertheless, compared to other major components such as carbohydrates, red macroalgae proteins remain underexploited. This review focuses on the potential of red algae as a protein source within an environmentally friendly biorefinery development strategy, primarily for food and biomedical applications. It also explores the strategies and limitations associated with protein extraction and purification, emphasizing the need for further in vivo and toxicological studies, particularly regarding the digestibility and bioavailability of red algal proteins., Universidade de Vigo/CISUG
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Nutritional evaluation of high-value alternative proteins extracted from legume defective seeds

  • Jimenez Gonzalez, Camila
  • Fernández De Castro, Laura
  • Torrado Agrasar, Ana María
  • Fuciños González, Clara
  • Díaz de Apodaca, Elena
  • Rúa Rodríguez, María Luisa
El elevado contenido proteico de leguminosas como Phaseolus vulgaris, Lens culinaris, Lupinus albus y Pisum sativum ha despertado un creciente interés en su incorporación a formulaciones alimentarias, lo que a su vez ha impulsado el aprovechamiento de los subproductos generados en su recolección. En este estudio se analizó la calidad nutricional y las potenciales aplicaciones de concentrados proteicos de cuatro legumbres obtenidos a partir de semillas defectuosas. Se determinó la composición aminoacídica, contenido de antinutrientes, digestibilidad in vitro y estabilidad estructural. También se realizaron determinaciones de la composición proximal, pigmentos, minerales y ensayos de bioactividad. El contenido de proteínas en todos los concentrados fue superior al 70 % y presentaron un perfil de aminoácidos equilibrado, cumpliendo con los requerimientos para individuos sanos. El concentrado de judía mostró niveles elevados de inhibidores de tripsina (53,27 ± 0,19 TIU/mg) y de compuestos fenólicos totales (0,82 ± 0,02 mg GAE/g), mientras que el de guisante tenía los niveles más elevados de ácido fítico (2,67 ± 0,02 %). La mayor estabilidad estructural fue la del concentrado de judía asociado también a la digestibilidad in vitro más baja (~20 %) en comparación con los restantes concentrados (60–70 %). La estrategia empleada y los resultados obtenidos permitirán identificar con mayor precisión el desarrollo de productos alimenticios de origen vegetal, abordando tanto la sostenibilidad como la mejora del valor nutricional, The high protein content of legumes, including P. vulgaris, L. culinaris, L. albus, and P. sativum, is increasingly valued in food formulations, driving interest in utilizing their by-products. This study evaluates the nutritional quality and applications of four legume protein concentrates derived from defective seeds. Analysis included amino acid composition, antinutrient presence, and in vitro digestion, along with structural analysis. Proximate composition, pigment, mineral, and bioactivity assays were also conducted. All concentrates surpassed 70 % protein concentration and presented a well-balanced amino acid profile meeting the requirements for healthy individuals. Bean concentrate exhibited elevated levels of trypsin inhibitor (53.27 ± 0.19 TIU/mg) and total phenolic compounds (0.82 ± 0.02 mg GAE/g), while pea concentrate showed the highest phytic acid content (2.67 ± 0.02 %). Bean concentrate displayed superior structural stability and lower in vitro protein digestibility (∼20 %), compared to the other concentrates (60–70 %). These findings optimize legume defective seeds utilization in plant-based products, addressing sustainability and enhancing nutritional value.
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Renin–angiotensin system in liver metabolism: gender differences and role of incretins

  • Mastoor , Zainab
  • Diz Chaves, Yolanda Maria
  • González Matías, Lucas Carmelo
  • Mallo Ferrer, Federico
The impaired hepatic lipids and carbohydrates metabolism result in various metabolic disorders, including obesity, diabetes, insulin resistance, hyperlipidemia and metabolic syndrome. The renin–angiotensin system (RAS) has been identified in the liver and it is now recognized as an important modulator of body metabolic processes. This review is intended to provide an update of the impact of the renin–angiotensin system on lipid and carbohydrate metabolism, regarding gender difference and prenatal undernutrition, specifically focused on the role of the liver. The discovery of angiotensin-converting enzyme 2 (ACE2) has renewed interest in the potential therapeutic role of RAS modulation. RAS is over activated in non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma. Glucagon-like peptide-1 (GLP-1) has been shown to modulate RAS. The GLP-I analogue liraglutide antagonizes hepatocellular steatosis and exhibits liver protection. Liraglutide has a negative effect on the ACE/AngII/AT1R axis and a positive impact on the ACE2/Ang(1-7)/Mas axis. Activation of the ACE2/Ang(1-7)/Mas counter-regulatory axis is able to prevent liver injuries. Angiotensin(1-7) and ACE2 shows more favorable effects on lipid homeostasis in males but there is a need to do more investigation in female models. Prenatal undernutrition exerts long-term effects in the liver of offspring and is associated with a number of metabolic and endocrine alterations. These findings provide a novel therapeutic regimen to prevent and treat many chronic diseases by accelerating the effect of the ACE2/Ang1-7/Mas axis and inhibiting the ACE/AngII/AT1R axis.
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases

  • Diz Chaves, Yolanda Maria
  • Mastoor , Zainab
  • Spuch Calvar, Carlos
  • González Matías, Lucas Carmelo
  • Mallo Ferrer, Federico
The glucagon-like peptide-1 (GLP-1) is a pleiotropic hormone well known for its incretin effect in the glucose-dependent stimulation of insulin secretion. However, GLP-1 is also produced in the brain and displays a critical role in neuroprotection and inflammation by activating the GLP-1 receptor signaling pathways. Several studies in vivo and in vitro using preclinical models of neurodegenerative diseases show that GLP-1R activation has anti-inflammatory properties. This review explores the molecular mechanistic action of GLP-1 RAS in relation to inflammation in the brain. These findings update our knowledge of the potential benefits of GLP-1RAS actions in reducing the inflammatory response. These molecules emerge as a potential therapeutic tool in treating neurodegenerative diseases and neuroinflammatory pathologies., European Union | Ref. H2020-BBIJTI- 2019-887259, Xunta de Galicia | Ref. ED431G/02